基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I completed my Bachelors of Science and medical degree at the University of Manitoba in Canada. This was followed by training in internal medicine in Winnipeg, Canada and a fellowship in rheumatology at the University of Toronto. I subsequently worked as an Arthritis Society of Canada/CIHR Research Fellow at the then Arthritis Research UK Epidemiology Unit in Manchester, being awarded my PhD in 2005. I joined this unit as a Senior Lecturer in 2006 and I am now Professor of Epidemiology at the University of Manchester, set in the Versus Arthritis Centre for Epidemiology, and an Honorary Rheumatology Consultant at Manchester University Hospitals NHS Foundation Trust, UK.
My main research interests centre on outcomes in inflammatory arthritis, with a particular focus on pharmacoepidemiology. I am a principal investigator for the British Society for Rheumatology Biologics Register (BSRBR), which is prospectively collecting information on all patients receiving biologic therapy for a rheumatic disease throughout the United Kingdom. Work from this project has assessed the real-world efficacy of anti-TNF agents for rheumatoid arthritis as well as predictors of response and the risk of adverse events, including infection and myocardial infarction. My research in paediatrics includes the Childhood Arthritis Prospective Study (CAPS), an inception cohort which is studying both short and long-term outcomes in children diagnosed in the UK with juvenile idiopathic arthritis and 2 biologic registers in children: the Arthritis Research UK funded Safety and Efficacy of Biologics in Children (Extended Biologics Study) and the BSPAR Etanercept Register, which is focusing on the short and long-term safety of the use of biologic drugs in children with arthritis. I am a member of the MRC Stratified Medicine Consortium for JIA called CLUSTER.
I supervise a number of PhD and Masters students working on these and related projects.
Most recently, during this COVID-19 Pandemic, I co-lead the EULAR COVID-19 Database, part of the CV-19 Global Rheumatology Alliance, as well as sit on a number of regional and national COVID expert working groups, including the Greater Manchester Mass Testing Expert Group.
My main research interests centre on outcomes in inflammatory arthritis, with a particular focus on pharmacoepidemiology. I am a principal investigator for the British Society for Rheumatology Biologics Register (BSRBR), which is prospectively collecting information on all patients receiving biologic therapy for a rheumatic disease throughout the United Kingdom. Work from this project has assessed the real-world efficacy of anti-TNF agents for rheumatoid arthritis as well as predictors of response and the risk of adverse events, including infection and myocardial infarction. My research in paediatrics includes the Childhood Arthritis Prospective Study (CAPS), an inception cohort which is studying both short and long-term outcomes in children diagnosed in the UK with juvenile idiopathic arthritis and 2 biologic registers in children: the Arthritis Research UK funded Safety and Efficacy of Biologics in Children (Extended Biologics Study) and the BSPAR Etanercept Register, which is focusing on the short and long-term safety of the use of biologic drugs in children with arthritis. I am a member of the MRC Stratified Medicine Consortium for JIA called CLUSTER.
I supervise a number of PhD and Masters students working on these and related projects.
Most recently, during this COVID-19 Pandemic, I co-lead the EULAR COVID-19 Database, part of the CV-19 Global Rheumatology Alliance, as well as sit on a number of regional and national COVID expert working groups, including the Greater Manchester Mass Testing Expert Group.
Research Interests
Papers共 369 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Richard Beesley, Freya Luling Feilding, CLUSTER Consortium Champions
,Elizabeth C Rosser,Stephanie J W Shoop-Worrall, Alyssia McNeece, Zoe Wanstall,Kimme Hyrich, Lucy R Wedderburn, CLUSTER Consortium
Rheumatology (Oxford, England)no. 3 (2024): e88-e91
Nasimah Maricar,Gillian Yeowell,Trixy David,Behram Khan,Anne Barton,Kimme L Hyrich, Sandra E Hartley
BMC Rheumatologyno. 1 (2024): 1-11
Annals of the rheumatic diseases (2024)
RHEUMATOLOGYno. 4 (2024): 1015-1021
Melissa L Mannion, Shahla Amin,Stephen Balevic,Min-Lee Chang,Colleen K Correll,Lianne Kearsley-Fleet,Kimme L Hyrich,Timothy Beukelman, Childhood Arthritis and Rheumatology Research Alliance Registry Investigators and the UK Juvenile Idiopathic Arthritis Biologics Register Investigators
Arthritis care & research (2024)
Jie Man Low,Kimme L Hyrich,Coziana Ciurtin,Flora McErlane, Lucy R Wedderburn,Nophar Geifman,Stephanie J W Shoop-Worrall, CAPS Principal Investigators
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn